oti pack e 3 ml
 

Pills
 

ED Pills

ED Drugs
 

H. pylori eradication agents


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Agents used in treatment of Helicobacter Pylori are medicines used for stomach acid inhibition, combined with antibacterial agents. Treatment is for one week with a proton pump inhibitor or an antacid (or antisecretory agents), and two appropriate antibacterial agents. This one week triple therapy does give a good eradication rate.

See also

Medical conditions associated with H. pylori eradication agents:

Helicobacter Pylori Infection Drug List: Prevpac-Therapy-Pack Pylera Helidac-Therapy-Pack
read more / Download


Sentry HC Worm X



Dosage Form: FOR ANIMAL USE ONLY
Broad Spectrum De-Wormer Chewable Tablets for Large Dogs INDICATIONS & USAGE

For Removal of Hookworms in Puppies and Dogs

Ancylostoma caninum Uncinaria stenocephala For Removal of Large Roundworms (Ascarids) in Puppies and Dogs
Toxocara canis Toxascaris leonina To Prevent Reinfection of Large Roundworms in Puppies, Adult Dogs and Lactating Bitches After Whelping
Toxocara canis ACTIVE INGREDIENT (in each chewable) Pyrantel Pamoate (113.5 mg) How is Sentry HC Worm X Supplied Net Contents:    2 Tablet Count
Net Contents:    4 Tablet Count
Net Contents:  12 Tablet Count STORAGE Store at controlled room temperature of 59-86 degrees F (15-30 degrees C). PACKAGE LABEL PRINCIPAL DISPLAY PANEL Sentry HC Worm X
Distributed by:
Sergeant's Pet Care Products, Inc., Omaha NE 68130
www.sentrypetcare.com
ANADA #200-281, Approved by FDA
Sentry HC Worm X 
pyrantel pamoate  tablet, chewable Product Information Product Type OTC ANIMAL DRUG NDC Product Code (Source) 21091-402 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PYRANTEL PAMOATE (PYRANTEL) PYRANTEL PAMOATE 113.5 mg Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color brown Score no score Shape ROUND Size 10mm Flavor LIVER (Pork Liver Powder) Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 21091-402-02 1 BLISTER PACK In 1 CARTON contains a BLISTER PACK 1 2 TABLET In 1 BLISTER PACK This package is contained within the CARTON (21091-402-02) 2 21091-402-04 2 BLISTER PACK In 1 CARTON contains a BLISTER PACK 2 4 TABLET In 1 BLISTER PACK This package is contained within the CARTON (21091-402-04) 3 21091-402-12 6 BLISTER PACK In 1 CARTON contains a BLISTER PACK 3 12 TABLET In 1 BLISTER PACK This package is contained within the CARTON (21091-402-12)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANADA ANADA200281 01/16/2008
Labeler - Sergeant's Pet Care Products, Inc. (876995171) Establishment Name Address ID/FEI Operations Virbac Bridgeton 808558100 manufacture Revised: 11/2010Sergeant's Pet Care Products, Inc.

read more / Download


Adrenogenital Syndrome Medications


Definition of Adrenogenital Syndrome: Congenital adrenal hyperplasia refers to a group of inherited disorders relating to the adrenal glands, characterized by a deficiency in the hormones cortisol and aldosterone and an overproduction of androgen. More...

Drugs associated with Adrenogenital Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Adrenogenital Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Adrenogenital Syndrome

Medical Encyclopedia:

Congenital adrenal hyperplasia
Drug List: A-Methapred-Solution Baycadron De-Sone-La-Injection Decadron Deltasone Depo-Medrol-Suspension Dexacen-4-Injection Dexacort-Phosphate-In-Turbinaire Dexamethasone-Intensol Dexasone-Injection Dexasone-La-Injection Dexpak-Tablets-Dose-Pack Florinef Florinef-Acetate Medrol Medrol-Dosepak Methylprednisolone-Dose-Pack Meticorten Solu-Medrol-Solution Solurex-Injection Solurex-La-Injection Sterapred Sterapred-Ds Zema-Pak-10-Day
read more / Download


Monistat 1 Combo Pack Cream


Pronunciation: mi-KON-a-zole
Generic Name: Miconazole
Brand Name: Monistat 1 Combo Pack
Monistat 1 Combo Pack Cream is used for:

Treating vaginal yeast infections and relieving external vulvar itching and irritation associated with yeast infection.

Monistat 1 Combo Pack Cream is an antifungal agent. It works by weakening the cell membrane of the fungus, resulting in the death of the fungus.

Do NOT use Monistat 1 Combo Pack Cream if: you are allergic to any ingredient in Monistat 1 Combo Pack Cream you have never had a vaginal yeast infection diagnosed by a doctor

Contact your doctor or health care provider right away if any of these apply to you.

Before using Monistat 1 Combo Pack Cream:

Some medical conditions may interact with Monistat 1 Combo Pack Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have the blood disease porphyria or a history of liver disease, or you have been exposed to HIV if you have stomach, shoulder, or lower back pain; fever; chills; nausea; foul-smelling vaginal discharge; or vomiting if this is the first time you have had vaginal itching and discomfort if you have vaginal yeast infections often (eg, once a month or 3 in 6 months) if you are taking antibiotics

Some MEDICINES MAY INTERACT with Monistat 1 Combo Pack Cream. Tell your health care provider if you are taking any other medicines, especially any of the following:

Anticoagulants (eg, warfarin) because the risk of side effects such as bruising or bleeding may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Monistat 1 Combo Pack Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Monistat 1 Combo Pack Cream:

Use Monistat 1 Combo Pack Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Monistat 1 Combo Pack Cream comes with an additional patient leaflet. Read it carefully and reread it each time you get Monistat 1 Combo Pack Cream refilled. Monistat 1 Combo Pack Cream is for vaginal use only. Do not use in the eyes or take by mouth. Suppositories - Using the applicator provided, insert the suppository high into the vagina at bedtime. External cream - Squeeze a small amount of cream onto your finger and gently spread the cream onto the itchy, irritated skin outside the vagina as directed by your doctor or on the packaging. Wash your hands immediately after using Monistat 1 Combo Pack Cream. To clear up your infection completely, continue using Monistat 1 Combo Pack Cream for the full course of treatment. If you miss a dose of Monistat 1 Combo Pack Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Monistat 1 Combo Pack Cream.

Important safety information: Monistat 1 Combo Pack Cream is for vaginal use only. Avoid contact with the eyes, nose, or mouth. If you get Monistat 1 Combo Pack Cream in your eyes, flush with a generous amount of cool water. It is important to use Monistat 1 Combo Pack Cream for the full course of treatment. Failure to do so may decrease the effectiveness of Monistat 1 Combo Pack Cream and increase the risk that the fungus will no longer be sensitive to Monistat 1 Combo Pack Cream and will not be able to be treated by this or certain other antibiotics in the future. If your symptoms do not improve within 3 days, if they last more than 7 days, or if they become worse, stop using Monistat 1 Combo Pack Cream and contact your health care provider at once. You may have a more serious illness. Do not use Monistat 1 Combo Pack Cream for itching caused by other conditions. Dry the outside vaginal area completely after showering, bathing, or swimming. Do not go swimming for at least 9 to 12 hours after applying Monistat 1 Combo Pack Cream. Change out of wet bathing suits or damp workout clothes as soon as possible. Continue using Monistat 1 Combo Pack Cream even during your menstrual period. Do not use tampons while you are using Monistat 1 Combo Pack Cream or until all of your symptoms go away. Use unscented pads or pantiliners. Do not have vaginal sexual intercourse while you are using Monistat 1 Combo Pack Cream. Monistat 1 Combo Pack Cream may decrease the effectiveness of condoms and diaphragms, increasing the chance of pregnancy or risk of sexually transmitted disease. Do not use these products for at least 1 day after treatment with Monistat 1 Combo Pack Cream. Do not use tampons, douches, spermicides, or other vaginal products while using Monistat 1 Combo Pack Cream. Overuse of topical products may worsen your condition. Do not use Monistat 1 Combo Pack Cream in CHILDREN younger than 12 years of age unless advised to do so by your health care provider. PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Monistat 1 Combo Pack Cream, discuss with your doctor the benefits and risks of using Monistat 1 Combo Pack Cream during pregnancy. It is unknown if Monistat 1 Combo Pack Cream is excreted in breast milk. If you are or will be breast-feeding while you are using Monistat 1 Combo Pack Cream, check with your doctor or pharmacist. Possible side effects of Monistat 1 Combo Pack Cream:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Headache; mild vaginal burning, irritation, or itching; stomach cramps.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever or chills; foul-smelling vaginal discharge; nausea; severe or prolonged vaginal burning, irritation, or itching; stomach pain; swelling; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Monistat Combo Pack side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Monistat 1 Combo Pack Cream:

Store Monistat 1 Combo Pack Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Do not use if the wrapper on the applicator or suppository is torn or damaged. Keep Monistat 1 Combo Pack Cream out of the reach of children and away from pets.

General information: If you have any questions about Monistat 1 Combo Pack Cream, please talk with your doctor, pharmacist, or other health care provider. Monistat 1 Combo Pack Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Monistat 1 Combo Pack Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More Monistat 1 Combo Pack resources Monistat 1 Combo Pack Side Effects (in more detail) Monistat 1 Combo Pack Use in Pregnancy & Breastfeeding Monistat 1 Combo Pack Drug Interactions 0 Reviews for Monistat Combo Pack - Add your own review/rating Compare Monistat 1 Combo Pack with other medications Vaginal Yeast Infection
read more / Download


Mycelex-7 Combo Pack Cream


Pronunciation: kloe-TRIM-a-zole
Generic Name: Clotrimazole
Brand Name: Mycelex-7 Combo Pack
Mycelex-7 Combo Pack Cream is used for:

Treating vaginal yeast infections and relieving external vulvar itching and irritation associated with yeast infection.

Mycelex-7 Combo Pack Cream is an antifungal agent. It works by weakening the cell membrane of the fungus, resulting in the death of the fungus.

Do NOT use Mycelex-7 Combo Pack Cream if: you are allergic to any ingredient in Mycelex-7 Combo Pack Cream you have never had a vaginal yeast infection diagnosed by a doctor you have itching caused by a condition other than a yeast infection you have stomach, shoulder, or lower back pain; fever; chills; nausea; foul-smelling vaginal discharge; or vomiting

Contact your doctor or health care provider right away if any of these apply to you.

Before using Mycelex-7 Combo Pack Cream:

Some medical conditions may interact with Mycelex-7 Combo Pack Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have the blood disease porphyria or a history of liver disease or diabetes, or you have been exposed to HIV if this is the first time you have had vaginal itching and discomfort if you have vaginal yeast infections often (eg, your symptoms return within 2 months) or your symptoms do not clear up with treatment if you are taking antibiotics

Some MEDICINES MAY INTERACT with Mycelex-7 Combo Pack Cream. However, no specific interactions with Mycelex-7 Combo Pack Cream are known at this time.

Ask your health care provider if Mycelex-7 Combo Pack Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Mycelex-7 Combo Pack Cream:

Use Mycelex-7 Combo Pack Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.

An extra patient leaflet is available with Mycelex-7 Combo Pack Cream. Talk to your pharmacist if you have questions about this information. Mycelex-7 Combo Pack Cream is for vaginal use only. Do not use it rectally or take by mouth. Suppositories - Using the applicator provided, insert 1 suppository high into the vagina at bedtime for 7 days. Mycelex-7 Combo Pack Cream comes with one applicator to be used for all 7 days of treatment. Do not throw away applicator after use. Separate the pieces of the applicator and wash with warm, soapy water immediately after use. Rinse thoroughly. Make sure the applicator is completely dry before the next use. External cream - Squeeze a small amount of cream onto your finger and gently spread the cream onto the itchy, irritated skin outside the vagina as directed by your doctor or on the packaging. Wash your hands immediately after using Mycelex-7 Combo Pack Cream. To clear up your infection completely, use Mycelex-7 Combo Pack Cream for the full course of treatment. Keep using it even if you feel better in a few days. If you miss a dose of Mycelex-7 Combo Pack Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Mycelex-7 Combo Pack Cream.

Important safety information: Mycelex-7 Combo Pack Cream is for vaginal use only. Avoid contact with the eyes, nose, or mouth. If you get Mycelex-7 Combo Pack Cream in your eyes, flush with a generous amount of cool water. Be sure to use Mycelex-7 Combo Pack Cream for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The bacteria could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future. If your symptoms do not improve within 3 days, if they last more than 7 days, or if they get worse, check with your doctor. Do not use Mycelex-7 Combo Pack Cream for itching caused by other conditions. Dry the outside vaginal area completely after showering, bathing, or swimming. Do not go swimming for at least 9 to 12 hours after applying Mycelex-7 Combo Pack Cream. Change out of wet bathing suits or damp workout clothes as soon as possible. Continue using Mycelex-7 Combo Pack Cream even during your menstrual period. Do not use tampons while you are using Mycelex-7 Combo Pack Cream or until all of your symptoms go away. Use unscented pads or pantiliners. Do not have vaginal sexual intercourse while you are using Mycelex-7 Combo Pack Cream. Mycelex-7 Combo Pack Cream may decrease the effectiveness of condoms and diaphragms, increasing the chance of pregnancy or risk of sexually transmitted disease. Do not use tampons, douches, spermicides, or other vaginal products while using Mycelex-7 Combo Pack Cream. If you use topical products too often, your condition may become worse. Mycelex-7 Combo Pack Cream should not be used in CHILDREN younger than 12 years old; safety and effectiveness in children have not been confirmed. PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Mycelex-7 Combo Pack Cream while you are pregnant. It is not known if Mycelex-7 Combo Pack Cream is found in breast milk. If you are or will be breast-feeding while you use Mycelex-7 Combo Pack Cream, check with your doctor. Discuss any possible risks to your baby. Possible side effects of Mycelex-7 Combo Pack Cream:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Headache; mild vaginal burning, irritation, or itching; stomach cramps.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever or chills; foul-smelling vaginal discharge; nausea; severe or prolonged vaginal burning, irritation, or itching; stomach pain; swelling; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Mycelex-7 Combo Pack side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Mycelex-7 Combo Pack Cream:

Store Mycelex-7 Combo Pack Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Avoid temperatures above 86 degrees F (30 degrees C). Avoid freezing. Store away from heat, moisture, and light. Do not store in the bathroom. Do not use if the wrapper on the applicator or suppository is torn or damaged. Keep Mycelex-7 Combo Pack Cream out of the reach of children and away from pets.

General information: If you have any questions about Mycelex-7 Combo Pack Cream, please talk with your doctor, pharmacist, or other health care provider. Mycelex-7 Combo Pack Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Mycelex-7 Combo Pack Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More Mycelex-7 Combo Pack resources Mycelex-7 Combo Pack Side Effects (in more detail) Mycelex-7 Combo Pack Use in Pregnancy & Breastfeeding Mycelex-7 Combo Pack Support Group 0 Reviews for Mycelex-7 Combo Pack - Add your own review/rating Compare Mycelex-7 Combo Pack with other medications Cutaneous Candidiasis Tinea Corporis Tinea Cruris Tinea Pedis Tinea Versicolor Vaginal Yeast Infection
read more / Download


E45 Cream (Forum Health Products Limited )


1. Name Of The Medicinal Product

E45 Cream

2. Qualitative And Quantitative Composition

Anhydrous Lanolin

 

1.0%

w/w

White Soft Paraffin

BP

14.5%

w/w

Light Liquid Paraffin

PhEur

12.6%

w/w

3. Pharmaceutical Form

A cream

4. Clinical Particulars 4.1 Therapeutic Indications

For the symptomatic relief of dry skin conditions, where the use of an emollient is indicated, such as flaking, chapped skin, ichthyosis, traumatic dermatitis, sunburn, the dry stage of eczema and certain dry cases of psoriasis.

4.2 Posology And Method Of Administration

For topical application.

Adults, Children, Babies and the Elderly - Apply to the affected part two or three times daily.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

The labelling states:

For external use only.

If symptoms persist, consult your doctor.

Keep all medicines out of the reach of children.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

No clinically significant interactions known.

4.6 Pregnancy And Lactation

The safety of E45 Cream in pregnancy and lactation has not been assessed but is thought unlikely to constitute a hazard.

4.7 Effects On Ability To Drive And Use Machines

No adverse effects known.

4.8 Undesirable Effects

Occasionally, hypersensitivity reactions, otherwise adverse effects are unlikely, but should they occur, may take the form of an allergic rash. Should this occur, use of the product should be discontinued.

4.9 Overdose

E45 cream is of low toxicity. If accidental ingestion occurs, conservative treatment only is required.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Lanolin, light liquid paraffin and white soft paraffin have emollient moisturising properties.

5.2 Pharmacokinetic Properties

Not applicable.

5.3 Preclinical Safety Data

There are no pre-clinical safety data of relevance to the consumer.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Empilan GMS, cetyl alcohol, sodium cetostearyl sulphate, carbomer, methyl hydroxybenzoate, propyl hydroxybenzoate, sodium hydroxide, citric acid monohydrate, purified water.

6.2 Incompatibilities

Compatibility problems may be encountered with the stronger acids, calcium, magnesium and aluminium salts, quaternary compounds, acridines, basic dyestuffs and alkaloids.

6.3 Shelf Life

Aluminium tubes and polypropylene tubs: 3 years.

All other containers: 2 years.

6.4 Special Precautions For Storage

Store below 25°C for polyethylene tubes and pump pack, made of polypropylene and polyethylene and consisting of a plastic bottle and a pump system with a dip tube. None for aluminium tubes and polypropylene tubs.

6.5 Nature And Contents Of Container

A collapsible aluminium tube, internally lacquered with a membrane seal and plastic screw cap. Pack sizes: 15, 50 or 100 g.

(The 100 g tube is for dispensing only. One hundred tubes will be packed in an outer carton, labelled with the same wording as an OTC pack and the additional statement 'For dispensing only - not for retail sale'.)

A polyethylene tube with membrane seal and plastic screw cap. Pack sizes 15 or 50 g.

A polypropylene securipot with a white polythene pilfer-proof screw cap. Pack sizes: 125, 350 or 500 g.

A white polypropylene jar with a white polyethylene push-on, tamper-evident closure. Pack sizes: 250, 300 or 500 g.

((The 500 g jar is for dispensing only. Thirty-six jars will be packed in an outer carton, labelled with the same wording as an OTC pack and the additional statement 'For dispensing only - not for retail sale'.)

A polypropylene securipot with a polythene pilfer-proof screw cap fitted with a HDPE or polypropylene dispenser having a polythene covered follower plate.

Pack sizes: 500 or 900 g.

A pump pack made of polypropylene and polyethylene, consisting of a plastic bottle and a pump system with a dip tube. Pack size: 500 g.

A pump pack made of polypropylene and polyethylene, consisting of a piston pump system with an airless dispenser. Pack size: 500g

Not all pack sizes are necessarily marketed.

6.6 Special Precautions For Disposal And Other Handling

None.

7. Marketing Authorisation Holder

Reckitt Benckiser Healthcare (UK) Limited

Wellcroft Road

Slough,

SL1 4AQ

United Kingdom

8. Marketing Authorisation Number(S)

PL 00063/0404

9. Date Of First Authorisation/Renewal Of The Authorisation

25th September 1991

10. Date Of Revision Of The Text

07/10/2011

11 DOSIMETRY

IF APPLICABLE

12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

IF APPLICABLE


read more / Download


Skin Cancer Medications


Definition of Skin Cancer:

Skin cancer is the uncontrolled growth of skin cells. If left unchecked, these cancer cells can spread from the skin into other tissues and organs.

There are different types of skin cancer. Basal cell carncinoma is the most common. Melanoma is less common, but more dangerous.

Drugs associated with Skin Cancer

The following drugs and medications are in some way related to, or used in the treatment of Skin Cancer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Skin Cancer Basal Cell Carcinoma (6 drugs) Melanoma (16 drugs in 2 topics) Squamous Cell Carcinoma (2 drugs) Learn more about Skin Cancer

Micromedex Care Notes:

Liposarcoma Squamous Cell Carcinoma

Medical Encyclopedia:

Skin cancer

Drugs.com Health Center:

Skin Cancer
Drug List: Carac-Cream Efudex-Cream Efudex-Occlusion-Pack Fluoroplex-Cream
read more / Download


Allergy Relief Tablets


loratadine
Dosage Form: tablet
Drug Facts Active ingredient

loratadine 10mg

Purpose

antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

• runny nose • itchy, watery eyes • sneezing • itching of the nose or throat

Warnings Adverse Reactions Do Not Use

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

Ask Doctor

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

When Using

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop Use

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

Pregnancy or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Keep Out of Reach of Children

Keep out of reach of children.

Overdose

In case of overdose, get medical help or contact a Poison Control Center right away.

Other Information safety sealed: do not use if the imprinted bottle seal with “sealed for your protection” is open or torn (for bottle carton only) safety sealed: do not use if the imprinted blister unit is open or torn (for blister carton only) store at 20-25°C (68-77°F) (see USP Controlled Room Temperature) Directions adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor Inactive ingredients

lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

Questions

call 1-800-452-0051

 

 Distributed by Target Corp.

Minneapolis, MN 55403

copyright 2009 Target Brands, Inc.

All Rights Persevered

Principal Display

Target


ALLERGY RELIEF MEDICATION 
loratadine  tablet Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 11673-315 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LORATADINE (LORATADINE) LORATADINE 10 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE   LACTOSE MONOHYDRATE   MAGNESIUM STEARATE   SODIUM STARCH GLYCOLATE TYPE A POTATO   Product Characteristics Color WHITE Score no score Shape ROUND Size 6mm Flavor Imprint Code GG;296 Contains          Packaging # NDC Package Description Multilevel Packaging 1 11673-315-10 2 BLISTER PACK In 1 CARTON contains a BLISTER PACK 1 5 TABLET In 1 BLISTER PACK This package is contained within the CARTON (11673-315-10) 2 11673-315-40 4 BLISTER PACK In 1 CARTON contains a BLISTER PACK 2 10 TABLET In 1 BLISTER PACK This package is contained within the CARTON (11673-315-40) 3 11673-315-18 1 BOTTLE In 1 CARTON contains a BOTTLE 3 180 TABLET In 1 BOTTLE This package is contained within the CARTON (11673-315-18) 4 11673-315-60 6 BLISTER PACK In 1 CARTON contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the CARTON (11673-315-60) 5 11673-315-30 3 BLISTER PACK In 1 CARTON contains a BLISTER PACK 5 10 TABLET In 1 BLISTER PACK This package is contained within the CARTON (11673-315-30) 6 11673-315-15 3 BLISTER PACK In 1 CARTON contains a BLISTER PACK 6 5 TABLET In 1 BLISTER PACK This package is contained within the CARTON (11673-315-15)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA075209 01/31/2010
Labeler - Target Brands, Inc. (006961700) Revised: 09/2010Target Brands, Inc. More Allergy Relief Tablets resources Allergy Relief Tablets Side Effects (in more detail) Allergy Relief Tablets Dosage Allergy Relief Tablets Use in Pregnancy & Breastfeeding Allergy Relief Tablets Drug Interactions 0 Reviews for Allergy Reliefs - Add your own review/rating Compare Allergy Relief Tablets with other medications Hay Fever Urticaria
read more / Download


Meningitis, Listeriosis Medications


Drugs associated with Meningitis, Listeriosis

The following drugs and medications are in some way related to, or used in the treatment of Meningitis, Listeriosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.


Drug List: Baycadron De-Sone-La-Injection Decadron Dexacen-4-Injection Dexacort-Phosphate-In-Turbinaire Dexamethasone-Intensol Dexasone-Injection Dexasone-La-Injection Dexpak-Tablets-Dose-Pack Solurex-Injection Solurex-La-Injection Zema-Pak-10-Day
read more / Download


Mycobacterium avium-intracellulare, Treatment Medications


Drugs associated with Mycobacterium avium-intracellulare, Treatment

The following drugs and medications are in some way related to, or used in the treatment of Mycobacterium avium-intracellulare, Treatment. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.


Drug List: Azithromycin-3-Day-Dose-Pack Biaxin Biaxin-Xl-Extended-Release-Tablets Cipro Cipro-I-V Cipro-Xr-Extended-Release-Tablets Floxin Myambutol Mycobutin Zithromax Zmax-Extended-Release-Oral-Suspension
read more / Download


Aqueous Cream BP (Boots Company plc)


1. Name Of The Medicinal Product

Aqueous Cream B.P.

2. Qualitative And Quantitative Composition

Active ingredient

% w/w

White Soft Paraffin BP

Liquid Paraffin BP

15.0

6.0

3. Pharmaceutical Form

Cream

4. Clinical Particulars 4.1 Therapeutic Indications

For the symptomatic relief of dry skin disorders.

For topical application to the skin.

4.2 Posology And Method Of Administration

Adults, children and elderly:

To be applied to the skin as required.

May also be used as a soap substitute.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

For external use only.

Keep all medicines out of the reach of children.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

No clinically significant drug interactions known.

4.6 Pregnancy And Lactation

The safety of aqueous cream during pregnancy and lactation has not been established but is not considered to constitute a hazard during these periods.

4.7 Effects On Ability To Drive And Use Machines

No adverse effects known.

4.8 Undesirable Effects

Occasional hypersensitivity reactions.

4.9 Overdose

Symptoms of accidental oral ingestion may include gastrointestinal symptoms, particularly diarrhoea. Treatment need only be symptomatic.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

White soft paraffin and liquid paraffin have emollient properties.

5.2 Pharmacokinetic Properties

None applicable.

5.3 Preclinical Safety Data

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Emulsifying wax

Chlorocresol

Purified water

6.2 Incompatibilities

Not applicable

6.3 Shelf Life

36 months

6.4 Special Precautions For Storage

Tub: Store in a cool place.

Tube: None

6.5 Nature And Contents Of Container

Polypropylene jar with an unlined polypropylene cap.

Pack size 500g.

or Polypropylene securitub with a white pilfer-proof polythene cap.

Pack size: 500g

or Pigmented LDPE/HDPE tube fitted with a polypropylene screw cap.

Pack sizes: 60g, 100g

or Laminate tube fitted with a polypropylene screw cap.

Pack sizes: 60g, 100g

6.6 Special Precautions For Disposal And Other Handling

Not applicable.

7. Marketing Authorisation Holder

The Boots Company PLC

Nottingham

NG2 3AA

Trading as: BCM

8. Marketing Authorisation Number(S)

PL 00014/5202R

9. Date Of First Authorisation/Renewal Of The Authorisation

First Authorisation: 16 December 1986

Renewal: 16 December 1991

10. Date Of Revision Of The Text

June 2009


read more / Download


Asystole Medications


Definition of Asystole:

Cardiac standstill or arrest, absence of a heartbeat.

Synonym: Beau's syndrome.

Drugs associated with Asystole

The following drugs and medications are in some way related to, or used in the treatment of Asystole. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Asystole

Medical Encyclopedia:

Heart attack Heart attack first aid
Drug List: Adrenaclick-Auto-Injector Adrenalin Adrenalin-Chloride Asthmahaler-Aerosol Epipen-Auto-Injector Epipen-2-Pak Epipen-Auto-Injector Epipen-Jr-Auto-Injector Epipen-Jr-2-Pak Epipen-Jr-Auto-Injector Medihaler-Epi Neut Pitressin Primatene-Mist-Aerosol Twinject-Auto-Injector Twinject-Auto-Injector Twinject-Auto-Injector-Two-Pack
read more / Download


Uveitis, Posterior Medications


Drugs associated with Uveitis, Posterior

The following drugs and medications are in some way related to, or used in the treatment of Uveitis, Posterior. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Uveitis, Posterior Infectious Posterior Uveitis (0 drugs) Learn more about Uveitis, Posterior

Medical Encyclopedia:

Uveitis
Drug List: Baycadron De-Sone-La-Injection Decadron Deltasone Dexacen-4-Injection Dexacort-Phosphate-In-Turbinaire Dexamethasone-Intensol Dexasone-Injection Dexasone-La-Injection Dexpak-Tablets-Dose-Pack Meticorten Ozurdex Solurex-Injection Solurex-La-Injection Sterapred Sterapred-Ds Zema-Pak-10-Day
read more / Download


Oilatum Cream


1. Name Of The Medicinal Product

Oilatum Cream

2. Qualitative And Quantitative Composition

Contains Light Liquid Paraffin 6.0% w/w and White Soft Paraffin 15.0% w/w in a cream base.

Also contains cetostearyl alcohol and potassium sorbate.

For a full list of excipients, see Section 6.1.

3. Pharmaceutical Form

Cream.

A white to off-white cream.

4. Clinical Particulars 4.1 Therapeutic Indications

Oilatum Cream is indicated in the treatment of contact dermatitis, atopic eczema, senile pruritus, ichthyosis and related dry skin conditions.

4.2 Posology And Method Of Administration

Oilatum Cream may be used as often as required. Apply to the affected area and rub in well. It is especially effective after washing when the sebum content of the stratum corneum may be depleted resulting in excessive moisture loss.

Oilatum Cream is suitable for adults, children and the elderly.

4.3 Contraindications

Should not be used in patients with known hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

Cetostearyl alcohol and potassium sorbate may cause local skin reactions (e.g. contact dermatitis).

Hospital users should follow local procedures and policies for using topical products on in-patients.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None

4.6 Pregnancy And Lactation

There are no restrictions on the use of Oilatum Cream during pregnancy or lactation.

4.7 Effects On Ability To Drive And Use Machines

None

4.8 Undesirable Effects

May cause irritation in patients hypersensitive to any of the ingredients

4.9 Overdose

Accidental ingestion may cause nausea and vomiting. Administer copious quantities of water as required. Excessive topical application should cause no untoward effects other than greasy skin.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Light Liquid Paraffin and White Soft Paraffin exert an emollient effect by forming an occlusive film which reduces trans-epidermal water loss, thus helping to maintain normal skin humidity levels. Polyvinyl pyrrolidone enhances the strength and longevity of the occlusive film formed by the oil on the skin.

5.2 Pharmacokinetic Properties

Not applicable

5.3 Preclinical Safety Data

White Soft Paraffin and Light Liquid Paraffin have been used in pharmaceutical and cosmetic preparations for many years. The formulation contains excipients that are commonly used in such preparations. The safety of these substances is well established by common use over long periods in man.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Macrogol 1000 Monostearate

Cetostearyl alcohol

Glycerol

Potassium sorbate

Benzyl alcohol

Citric acid monohydrate

Povidone

Purified water

6.2 Incompatibilities

None

6.3 Shelf Life

Pack sizes 25g, 30g 40g, 50g, 80g, 100g and 150g: Three years

Pack sizes 350ml, 500ml, 1000ml, 1050ml, 1100ml and 1150ml: 30 Months

6.4 Special Precautions For Storage

Store below 25 ?C

6.5 Nature And Contents Of Container

Internally lacquered, membrane sealed aluminium tube fitted with a polypropylene screw cap and packed into a carton. Pack size 40g and 80g.

Internally lacquered, membrane sealed aluminium tube fitted with a polyethylene screw cap and packed into a carton. Pack size 30g and 50g.

Laminate tubes with polypropylene caps packed into cartons: Pack sizes 100g and 150g.

And 25g, 50g and 150g in a high density polyethylene tube.

350ml and 500ml pump pack: high density polyethylene bottle fitted with a mechanical pump dispenser (polyethylene/ polypropylene components).

1000ml, 1050ml, 1100ml and 1150ml pump pack: polypropylene container and lid, fitted with a mechanical pump dispenser (polypropylene components), utilising a follower plate (HDPE).

Not all pack sizes may be marketed.

6.6 Special Precautions For Disposal And Other Handling

None

7. Marketing Authorisation Holder

GlaxoSmithKline UK Limited

980 Great West Road

Brentford

Middlesex

TW8 9GS

Trading as Stiefel

Stockley Park West

Uxbridge

Middlesex

UB11 1BT

8. Marketing Authorisation Number(S)

Pack sizes 25g, 30g, 40g, 50g, 80g, 100g and 150g: PL 19494/0072

Pack sizes 350ml, 500ml, 1000ml, 1050ml, 1100ml and 1150ml: PL 19494/0076

9. Date Of First Authorisation/Renewal Of The Authorisation

Date of first authorisation PL19494/0072: 24th January 2001/7 December 2010

Date of first authorisation PL19494/0076: 28th October 2005

10. Date Of Revision Of The Text

PL19494/0072: 19 August 2011

PL 19494/0076: 22 February 2011


read more / Download


Meningitis, Haemophilus influenzae Medications


Drugs associated with Meningitis, Haemophilus influenzae

The following drugs and medications are in some way related to, or used in the treatment of Meningitis, Haemophilus influenzae. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Meningitis, Haemophilus influenzaeHaemophilus influenzae Prophylaxis (12 drugs)
Drug List:/tags/baycadron/
/tags/decadron/
/tags/dexacort-phosphate-in-turbinaire/
/tags/dexasone-injection/
/tags/dexpak-tablets-dose-pack/
/tags/gantrisin-pediatric/
/tags/solurex-la-injection/
Zema-Pak-10-Day
read more / Download


Mountain Sickness / Altitude Sickness Medications


Definition of Mountain Sickness / Altitude Sickness: Acute mountain sickness is an illness that can affect mountain climbers, hikers, skiers, or travelers who ascend too rapidly to high altitude (typically above 8,000 feet or 2,400 meters). This is especially for persons who normally reside at or near sea level.

Drugs associated with Mountain Sickness / Altitude Sickness

The following drugs and medications are in some way related to, or used in the treatment of Mountain Sickness / Altitude Sickness. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.


Drug List:/tags/baycadron/
/tags/decadron/
/tags/dexacort-phosphate-in-turbinaire/
/tags/dexasone-injection/
/tags/dexpak-tablets-dose-pack/
/tags/diamox-sequels-sustained-release-capsules/
/tags/solurex-la-injection/

read more / Download


Addison's Disease Medications


Definition of Addison's Disease: A rare endocrine disease that results from the underproduction of aldosterone and cortisol

Drugs associated with Addison's Disease

The following drugs and medications are in some way related to, or used in the treatment of Addison's Disease. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Addison's Disease

Micromedex Care Notes:

Addison's Disease Secondary Adrenal Insufficiency

Medical Encyclopedia:

Addison's disease
Drug List: A-Hydrocort Baycadron Cortef De-Sone-La-Injection Decadron Dexacen-4-Injection Dexacort-Phosphate-In-Turbinaire Dexamethasone-Intensol Dexasone-Injection Dexasone-La-Injection Dexpak-Tablets-Dose-Pack Florinef Florinef-Acetate Hydrocortone Solu-Cortef-Solution Solurex-Injection Solurex-La-Injection Zema-Pak-10-Day
read more / Download


Monistat 7 Combination Pack


miconazole nitrate
Dosage Form: cream
Monistat 7 Combination Pack Triple Action

Drug Facts

Active ingredients Purpose Miconazole nitrate 2% (100 mg in each applicatorful) Vaginal antifungal Miconazole nitrate 2% (external cream) Vaginal antifungal Uses treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection Warnings

For vaginal use only

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

Ask a doctor before use if you have

vaginal itching and discomfort for the first time lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition. vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. been exposed to the human immunodeficiency virus (HIV) that causes AIDS

Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur

When using this product

do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs). do not have vaginal intercourse mild increase in vaginal burning, itching or irritation may occur if you do not get complete relief ask a doctor before using another product

Stop use and ask a doctor if

symptoms do not get better in 3 days symptoms last more than 7 days you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions before using this product, read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: applicators: insert 1 applicatorful into the vagina at bedtime for 7 nights in a row. Throw away applicator after use. external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vulva). Use 2 times daily for up to 7 days, as needed. children under 12 years of age: ask a doctor Other information

do not use if seal over tube opening has been punctured or embossed design

do not purchase if carton is open store at 20°-25°C (68°-77°F) Inactive ingredients benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol Questions?

If you have any questions or comments, please call 1-877-666-4782

PRINCIPAL DISPLAY PANEL - Kit Carton

NDC-30014-003-07

MONISTAT®7
COMBINATION PACK
Miconazole Nitrate Cream (2%) and Miconazole Nitrate Cream (2%)

(Miconazole Nitrate 100 mg per applicator)

ORTHO
CLINICALLY PROVEN
Multi-Symptom Relief

VAGINAL ANTIFUNGAL

CURES MOST VAGINAL YEAST INFECTIONS AND
RELIEVES ASSOCIATED EXTERNAL ITCHING AND IRRITATION

7-Day Vaginal Cream with Disposable Applicators
PLUS External Cream

Net Wt. 1.59 oz. (45g)
+ 0.32 oz. (9g) Tube


Monistat 7 Combination Pack  TRIPLE ACTION
miconazole nitrate  kit Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 30014-003 Packaging # NDC Package Description Multilevel Packaging 1 30014-003-07 1 KIT In 1 PACKAGE, COMBINATION None QUANTITY OF PARTS Part # Package Quantity Total Product Quantity Part 1 1 TUBE, WITH APPLICATOR   0.1 g Part 2 1 TUBE   0.009 g Part 1 of 2 MICONAZOLE NITRATE 
miconazole nitrate  cream Product Information       Route of Administration VAGINAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Miconazole Nitrate (Miconazole) Miconazole Nitrate 20 mg  in 1 g Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 0.1 g In 1 TUBE, WITH APPLICATOR None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA017450 04/10/2010
Part 2 of 2 MICONASOLE NITRATE 
miconazole nitrate  cream Product Information       Route of Administration VAGINAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Miconazole Nitrate (Miconazole) Miconazole Nitrate 20 mg  in 1 g Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 0.009 g In 1 TUBE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA017450 04/10/2010
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA017450 04/10/2010
Labeler - McNeil, PPC, Inc. (801375143) Revised: 04/2010McNeil, PPC, Inc.
More Monistat 7 Combination Pack resources Monistat 7 Combination Pack Side Effects (in more detail) Monistat 7 Combination Pack Use in Pregnancy & Breastfeeding Monistat 7 Combination Pack Drug Interactions Monistat 7 Combination Pack Support Group 0 Reviews for Monistat 7 Combination Pack - Add your own review/rating Compare Monistat 7 Combination Pack with other medications Vaginal Yeast Infection
read more / Download


Efudex Occlusion Pack


Generic Name: fluorouracil topical (flore oh YER a sill)
Brand Names: Carac, Efudex, Efudex Occlusion Pack, Fluoroplex

What is Efudex Occlusion Pack (fluorouracil topical)?

Fluorouracil interferes with the growth of skin cells. Fluorouracil works by causing the death of cells which are growing fastest, such as abnormal skin cells.

Fluorouracil topical is used to treat scaly overgrowths of skin (actinic or solar keratoses). Fluorouracil topical may also be used in the treatment of superficial basal cell carcinoma.

Fluorouracil topical may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about Efudex Occlusion Pack (fluorouracil topical)? Do not use fluorouracil topical on skin that is irritated, peeling, or infected or on open wounds. Wait until these conditions have fully healed before using fluorouracil topical. Fluorouracil topical is in the FDA pregnancy category X. This means that it is known to harm an unborn baby. Miscarriage and birth defects have been reported when fluorouracil topical was applied to mucous membrane areas by pregnant women. Do not use fluorouracil topical if you are pregnant or planning a pregnancy. Discuss with your doctor appropriate forms of birth control before starting treatment with fluorouracil topical.

Fluorouracil topical is available in a number of strengths and forms (creams and solutions). It is very important that you use the correct form and strength. Contact your doctor or pharmacist if you have questions regarding which product to use.

Avoid exposure to sunlight or artificial UV rays (e.g., sun lamps) during and immediately following treatment with fluorouracil topical. Use a sunscreen with a minimum sun protection factor (SPF) 15 and wear protective clothing when sun exposure is unavoidable. Individuals with fair skin may require a sunscreen with a higher SPF rating. What should I discuss with my healthcare provider before using Efudex Occlusion Pack (fluorouracil topical)?

Before using fluorouracil topical, tell your doctor if you:

have ever had an allergic reaction to another form of fluorouracil topical (Carac, Efudex, Fluoroplex) or injectable fluorouracil (Adrucil, 5-FU); or

have dihydropyrimidine dehydrogenase (DPD) enzyme deficiency.

You may not be able to use fluorouracil topical, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.

Fluorouracil topical is in the FDA pregnancy category X. This means that it is known to harm an unborn baby. Miscarriage and birth defects have been reported when fluorouracil topical was applied to mucous membrane areas by pregnant women. Do not use fluorouracil topical if you are pregnant or planning a pregnancy. Discuss with your doctor appropriate forms of birth control before starting treatment with fluorouracil topical. It is not known whether fluorouracil topical passes into breast milk. Do not use fluorouracil topical without first talking to your doctor if you are breast-feeding a baby. The safety and effectiveness of fluorouracil topical in patients younger than 18 years of age have not been established. How should I use Efudex Occlusion Pack (fluorouracil topical)?

Use fluorouracil topical exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Fluorouracil topical is available in a number of strengths and forms (creams and solutions). It is very important that you use the correct form and strength. Contact your doctor or pharmacist if you have questions regarding which product to use.

Clean the area where you will apply fluorouracil topical. Rinse well and dry the area with a towel and wait ten minutes before applying the medication.

Wash your hands before and immediately after applying this medication, unless it is being used to treat a hand condition.

Apply fluorouracil topical to the affected area with the finger tips or a non-metal applicator, smoothing it gently onto the affected skin. Use enough to cover the entire area with a thin film.

Fluorouracil topical should not be applied on the eyelids or in the eyes, nose, or mouth. Use caution when applying fluorouracil topical around the eyes, nose, or mouth. Do not use fluorouracil topical on skin that is irritated, peeling, or infected or on open wounds. Wait until these conditions have fully healed before using fluorouracil topical.

Do not cover the area after applying fluorouracil topical. This could cause too much medicine to be absorbed by the body and could be harmful. If a covering is needed, ask your doctor if a porous gauze dressing may be used.

A moisturizer or sun screen may be applied 2 hours after fluorouracil topical has been applied. Do not use any other skin products including creams, lotions, medications, or cosmetics unless instructed by your doctor.

The reaction of the skin treated with fluorouracil topical may be unsightly during treatment, and sometimes, for several weeks after completion of therapy.

Store fluorouracil topical at room temperature away from moisture and heat. What happens if I miss a dose?

Apply the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the dose you missed and apply only the next regularly scheduled dose. Do not apply a double dose of this medication.

What happens if I overdose? An overdose of fluorouracil topical is unlikely to occur. If you do suspect an overdose, or if fluorouracil topical has been ingested, call a poison control center or an emergency room for advice. What should I avoid while using Efudex Occlusion Pack (fluorouracil topical)? Do not use other prescription or over-the-counter skin products without first talking to your doctor during treatment with fluorouracil topical. They may interfere with the treatment or increase irritation of the skin. Avoid exposure to sunlight or artificial UV rays (e.g., sun lamps) during and immediately following treatment with fluorouracil topical. Use a sunscreen with a minimum sun protection factor (SPF) 15 and wear protective clothing when sun exposure is unavoidable. Individuals with fair skin may require a sunscreen with a higher SPF rating. Efudex Occlusion Pack (fluorouracil topical) side effects Serious side effects are not likely to occur. Stop using fluorouracil topical and seek emergency medical attention if you experience an allergic reaction (shortness of breath; closing of your throat; swelling of your lips, face, or tongue; or hives).

Fluorouracil topical may cause skin irritation, dryness, scaling or peeling (exfoliation), rash, and other local reactions. Eye irritation has also been reported. If these side effects are excessive or worsen with continued treatment, contact your doctor.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Efudex Occlusion Pack (fluorouracil topical)? Do not use other prescription or over-the-counter skin products without first talking to your doctor during treatment with fluorouracil topical. They may interfere with treatment or increase irritation to the skin.

Drugs other than those listed here may also interact with fluorouracil topical. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

More Efudex Occlusion Pack resources Efudex Occlusion Pack Side Effects (in more detail)Efudex Occlusion Pack Use in Pregnancy & BreastfeedingEfudex Occlusion Pack Support Group0 Reviews for Efudex Occlusion Pack - Add your own review/rating Carac Cream MedFacts Consumer Leaflet (Wolters Kluwer) Carac Prescribing Information (FDA) Carac Topical Advanced Consumer (Micromedex) - Includes Dosage Information Efudex Prescribing Information (FDA) Fluoroplex Prescribing Information (FDA) Compare Efudex Occlusion Pack with other medications Actinic KeratosisBasal Cell CarcinomaSkin Cancer Where can I get more information? Your pharmacist has additional information about fluorouracil topical written for health professionals that you may read.

See also: Efudex Occlusion Pack side effects (in more detail)


read more / Download


AlleRx Dose Pack Sustained-Release Tablets


Pronunciation: SOO-doe-e-FED-rin/METH-skoe-POL-a-meen with FEN-il-EF-rin/KLOR-fen-IR-a-meen/METH-skoe-POL-a-meen
Generic Name: Pseudoephedrine/Methscopolamine
Brand Name: AlleRx Dose Pack
AlleRx Dose Pack Sustained-Release Tablets are used for:

Relieving congestion, sneezing, runny nose, and itchy, watery eyes caused by allergies. It may also be used for other conditions as determined by your doctor.

AlleRx Dose Pack Sustained-Release Tablets are a combination pack containing a morning dose and an evening dose. The morning dose has a decongestant and an anticholinergic medicine. The evening dose has a decongestant, an antihistamine, and an anticholinergic medicine. The decongestant works by shrinking swollen tissue in the nose. The antihistamine works by blocking histamine, a substance in the body that causes sneezing, runny nose, and watery eyes. The anticholinergic works by drying mucous membranes in the nose and chest.

Do NOT use AlleRx Dose Pack Sustained-Release Tablets if: you are allergic to any ingredient in AlleRx Dose Pack Sustained-Release Tablets you are breast-feeding you are taking droxidopa, furazolidone, a phosphodiesterase inhibitor (eg, sildenafil), sodium oxybate (GHB), or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine), or you have taken an MAOI within the past 14 days you have severe heart blood vessel problems, severe high blood pressure, narrow-angle glaucoma, difficulty urinating, peptic ulcer, or uncontrolled bleeding you are having an asthma attack

Contact your doctor or health care provider right away if any of these apply to you.

Before using AlleRx Dose Pack Sustained-Release Tablets:

Some medical conditions may interact with AlleRx Dose Pack Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you are taking or have taken medicine for high blood pressure or depression in the last 14 days if you have a bladder blockage, an enlarged prostate, or trouble urinating if you have blood vessel problems (eg, hardening of the arteries), diabetes, glaucoma or increased pressure in the eye, heart problems (eg, irregular heartbeat, heart failure), high blood pressure, kidney problems, liver problems, lung or breathing problems (eg asthma, sleep apnea), a hiatal hernia, an adrenal gland tumor (pheochromocytoma), myasthenia gravis (muscle weakness), nerve problems (eg, neuropathy), stomach or bowel problems (eg, constipation, ulcerative colitis, motility problems, blockage), trouble sleeping, or an overactive thyroid if you have a history of alcohol abuse if you take potassium chloride tablets

Some MEDICINES MAY INTERACT with AlleRx Dose Pack Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

Droxidopa or sodium oxybate (GHB) because the risk of severe drowsiness, breathing problems, seizures, irregular heartbeat, or heart attack may be increased Alkalinizers (eg, sodium bicarbonate), anticholinergics (eg, benztropine, dicyclomine), antipsychotics (eg, chlorpromazine), beta-blockers (eg, propranolol), carbonic anhydrase inhibitors (eg, acetazolamide), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, MAOIs (eg, phenelzine), phosphodiesterase inhibitors (eg, sildenafil), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of AlleRx Dose Pack Sustained-Release Tablets's side effects Bromocriptine or digoxin because the risk of their side effects may be increased by AlleRx Dose Pack Sustained-Release Tablets Guanadrel, guanethidine, mecamylamine, methyldopa, reserpine, or other medicine for high blood pressure because their effectiveness may be decreased by AlleRx Dose Pack Sustained-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if AlleRx Dose Pack Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use AlleRx Dose Pack Sustained-Release Tablets:

Use AlleRx Dose Pack Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Take AlleRx Dose Pack Sustained-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation. Swallow AlleRx Dose Pack Sustained-Release Tablets whole. Do not break, crush, or chew before swallowing. This product contains 2 different tablets; one for the morning and one for the evening. Be sure you understand how to take AlleRx Dose Pack Sustained-Release Tablets. Check with your doctor or pharmacist if you are not sure which tablet to take in the morning or in the evening. Do not take AlleRx Dose Pack Sustained-Release Tablets at the same time as antacids, certain medicines for diarrhea (eg, kaolin, pectin, attapulgite, bismuth), or ketoconazole. Take these medicines 2 or 3 hours before or after taking AlleRx Dose Pack Sustained-Release Tablets. If you miss a dose of AlleRx Dose Pack Sustained-Release Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use AlleRx Dose Pack Sustained-Release Tablets.

Important safety information: AlleRx Dose Pack Sustained-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use AlleRx Dose Pack Sustained-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it. Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using AlleRx Dose Pack Sustained-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. AlleRx Dose Pack Sustained-Release Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking AlleRx Dose Pack Sustained-Release Tablets. AlleRx Dose Pack Sustained-Release Tablets may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking AlleRx Dose Pack Sustained-Release Tablets for a few days before the tests. AlleRx Dose Pack Sustained-Release Tablets may cause dry mouth. To relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute. AlleRx Dose Pack Sustained-Release Tablets may make your eyes more sensitive to sunlight. It may help to wear sunglasses. AlleRx Dose Pack Sustained-Release Tablets may reduce sweating. Do not become overheated in hot weather or while you are being active; heatstroke may occur. AlleRx Dose Pack Sustained-Release Tablets contains the stimulants phenylephrine and pseudoephedrine. Do not take diet or appetite control medicines while you are taking AlleRx Dose Pack Sustained-Release Tablets without checking with your doctor. AlleRx Dose Pack Sustained-Release Tablets has pseudoephedrine, phenylephrine, and an antihistamine in it. Before you start any new medicine, check the label to see if it has pseudoephedrine, phenylephrine, or an antihistamine in it too. If it does or if you are not sure, check with your doctor or pharmacist. Diabetes patients - AlleRx Dose Pack Sustained-Release Tablets may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine. Use AlleRx Dose Pack Sustained-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects. AlleRx Dose Pack Sustained-Release Tablets should not be used in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed. PREGNANCY and BREAST-FEEDING: It is not known if AlleRx Dose Pack Sustained-Release Tablets can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using AlleRx Dose Pack Sustained-Release Tablets while you are pregnant. AlleRx Dose Pack Sustained-Release Tablets are found in breast milk. Do not breast-feed while taking AlleRx Dose Pack Sustained-Release Tablets.

When used for long periods of time, AlleRx Dose Pack Sustained-Release Tablets may not work as well. This is known as TOLERANCE. Increasing the dose may cause toxic side effects to occur. If you suddenly stop taking AlleRx Dose Pack Sustained-Release Tablets, WITHDRAWAL symptoms, including worsening of congestion, may occur.

Possible side effects of AlleRx Dose Pack Sustained-Release Tablets:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; dizziness; drowsiness; dry mouth, nose, or throat; excitability or irritability (especially in children); giddiness; headache; lack of energy; lightheadedness; nausea; nervousness; trouble sleeping; unusual tiredness or weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fast or irregular heartbeat; flushing; hallucinations; mental or mood changes; seizures; severe drowsiness or dizziness; tremor; trouble urinating; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: AlleRx Dose Pack side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org), or emergency room immediately. Symptoms may include deep sleep or loss of consciousness; hot or cool skin; fast or irregular heartbeat; large pupils; seizures; severe irritability, anxiety, or panicked feeling; slowed or shallow breathing; vomiting.

Proper storage of AlleRx Dose Pack Sustained-Release Tablets:

Store AlleRx Dose Pack Sustained-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep AlleRx Dose Pack Sustained-Release Tablets out of the reach of children and away from pets.

General information: If you have any questions about AlleRx Dose Pack Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider. AlleRx Dose Pack Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about AlleRx Dose Pack Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More AlleRx Dose Pack resources AlleRx Dose Pack Side Effects (in more detail) AlleRx Dose Pack Use in Pregnancy & Breastfeeding AlleRx Dose Pack Drug Interactions AlleRx Dose Pack Support Group 0 Reviews for AlleRx Dose Pack - Add your own review/rating Compare AlleRx Dose Pack with other medications Cold Symptoms Hay Fever
read more / Download


Related Search:

Search


 

Best ED Pills

 

Erectile Dysfunction

 

RX Pharmacy Drugs List - Buy Pills Online

RSS | Site Map | Map | PageMap

Copyright © Online Pharmacy Drug Store. All rights reserved.